Company Description
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States.
The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment.
It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.
The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies.
The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida.
It markets its scanners to private diagnostic imaging centers and hospitals.
The company was incorporated in 1978 and is based in Melville, New York.
Country | United States |
IPO Date | Oct 29, 1981 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 520 |
CEO | Timothy R. Damadian M.D. |
Contact Details
Address: 110 Marcus Drive Melville, New York United States | |
Website | https://www.fonar.com |
Stock Details
Ticker Symbol | FONR |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | 0000355019 |
CUSIP Number | 344437405 |
ISIN Number | US3444374058 |
Employer ID | 11-2464137 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Timothy R. Damadian M.D. | Chairman, President, Chief Executive Officer & Treasurer |
Luciano B. Bonanni | Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer |
Claudette J. V. Chan | Secretary & Director |
Daniel Culver | Director of Communications |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 13, 2024 | 8-K | Current Report |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 13, 2024 | SCHEDULE 13G | Filing |
Nov 12, 2024 | 8-K | Current Report |
Nov 12, 2024 | 10-Q | Quarterly Report |
Sep 30, 2024 | 8-K | Current Report |
Sep 27, 2024 | 10-K | Annual Report |
May 21, 2024 | 8-K | Current Report |
May 16, 2024 | 8-K | Current Report |
May 15, 2024 | 10-Q | Quarterly Report |